Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.
Completed
- Conditions
- Hepatocellular Carcinoma
- Registration Number
- NCT01890291
- Lead Sponsor
- GC Cell Corporation
- Brief Summary
To observation that long term follow-up study of 'Immuncell-LC groups' and 'Non-treatment groups' in patient undergo curative resection (PEIT, RFA or Operation) for hepatocellular carcinoma in Korea
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 162
Inclusion Criteria
- Prior to the test, patient is fully explained about the purpose/ contents and characteristics of the testing medication, and the patient him(her)self, the guardian or the legal representative signed on written consent.
- Patients of participated in the(ClinicalTrials.gov Identifier:NCT00699816)clinical trial.
Exclusion Criteria
- Patient who is incongruent to this clinical trial by sub-investigator's opinion.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate recurrence-free survival up to 3 years Radiological test should be operated by dynamic CT(using 64 cut), dynamic MRI or by angiography.
- Secondary Outcome Measures
Name Time Method To determine the response rate to evaluate overall survival and cause specific survival and changes of Alpha feto protein (AFP) figures from baseline to the last observation date. up to 3 years
Trial Locations
- Locations (5)
Seoul National Hospital
🇰🇷Seoul, Korea, Republic of
Asan Medical Center
🇰🇷Seoul, Korea, Republic of
Korea University Guro Hospital
🇰🇷Seoul, Korea, Republic of
Korea University Ansan Hospital
🇰🇷Seoul, Korea, Republic of
Samsung Medical Center
🇰🇷Seoul, Korea, Republic of